PMID: 9437796Jan 23, 1998Paper

Phenolphthalein induces thymic lymphomas accompanied by loss of the p53 wild type allele in heterozygous p53-deficient (+/-) mice

Toxicologic Pathology
J K DunnickJ E French

Abstract

Epidemiology studies have indicated that many human cancers are influenced by environmental factors. Genetically altered mouse model systems offer us the opportunity to study the interaction of chemicals with genetic predisposition to cancer. Using the heterozygous p53-deficient (+/-) mouse, an animal model carrying one wild type p53 gene and one p53 null allele, we studied the effects of phenolphthalein on tumor induction and p53 gene alterations. Earlier studies showed that phenolphthalein caused carcinogenic effects in Fisher 344 rats and B6C3F1 mice after a 2-yr dosing period (Dunnick and Hailey, Cancer Res. 56: 4922-4926, 1996). The p53 (+/-) mice received phenolphthalein in the feed at concentrations of 200, 375, 750, 3,000, or 12,000 ppm (approximately 43, 84, 174, 689, or 2,375 mg/kg body weight/day or 129, 252, 522, 2,867, or 7,128 mg/m2 body surface area/day) for up to 6 mo. A target organ cancer site that accumulated p53 protein in the B6C3F1 mouse (i.e., thymic lymphoma) was also a target site for cancer in the p53 (+/-) mouse. In the p53 (+/-) mouse, treatment-related atypical hyperplasia and malignant lymphoma of thymic origin were seen in the control and dosed groups at a combined incidence of 0, 5, 5, 25, 100, a...Continue Reading

References

Jul 5, 1991·Science·M HollsteinC C Harris
Oct 1, 1988·The Journal of Allergy and Clinical Immunology·T MarshallW W Busse
Jan 1, 1987·Breast Cancer Research and Treatment·P M RavdinV C Jordan
Jan 1, 1986·Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology·G E Dinse, J K Haseman
Jan 1, 1985·Archives of Toxicology. Supplement. = Archiv Für Toxikologie. Supplement·K S Korach, J A McLachlan
Dec 1, 1974·The Journal of Pharmacy and Pharmacology·J H Gustafson, L Z Benet
Jan 1, 1995·Mutation Research·K L WittM D Shelby
Sep 1, 1995·Molecular Carcinogenesis·L A DonehowerA Bradley
Jun 1, 1995·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·L S Cox, D P Lane
Nov 1, 1993·Nature Genetics·M HarveyL A Donehower
Jan 1, 1993·Annual Review of Biochemistry·A J Levine
Jan 1, 1996·Reviews of Physiology, Biochemistry and Pharmacology·C Götz, M Montenarh
Jun 28, 1996·Cell·T MummenbrauerF Grosse
Dec 16, 1997·International Journal of Cancer. Journal International Du Cancer·T TsutsuiJ C Barrett
Jun 1, 1994·Environmental Health Perspectives·R L MelnickJ C Barrett
Dec 1, 1967·The Biochemical Journal·P MillburnR T Williams

❮ Previous
Next ❯

Citations

Sep 6, 2001·Diseases of the Colon and Rectum·J H Xing, E E Soffer
Dec 7, 2000·Mutation Research·M J ArmstrongS M Galloway
Oct 15, 1998·Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association·H EnzmannG M Williams
Dec 31, 2002·Toxicology·Kunitoshi Mitsumori
Apr 27, 2001·Toxicology Letters·R C SillsM L Cunningham
Nov 1, 2006·Toxicologic Pathology·Robert D CardiffJerrold M Ward
Oct 28, 2006·Toxicologic Pathology·Gail Pearse
Jan 5, 2012·Toxicologic Pathology·Jerrold M WardHerbert C Morse
Apr 5, 2003·Environmental Health Perspectives·John B PritchardJoseph K Haseman
Aug 7, 2010·Drugs·James L RoerigChristie Zunker
Apr 25, 2000·Drug Metabolism Reviews·B A Schwetz
Mar 5, 2016·Environmental Science and Pollution Research International·Domingos Lusitaneo Pier MacuveleJonas Valente Matsinhe
Apr 25, 2015·Pharmacoepidemiology and Drug Safety·Baofang LiangJianwei Su
Aug 30, 2013·Critical Reviews in Toxicology·David A EastmondBabasaheb Sonawane
Aug 20, 2002·The Journal of Veterinary Medical Science·Takeki UeharaKunitoshi Mitsumori
Feb 20, 2015·Toxicologic Pathology·Genevieve S BondyRekha Mehta
Jun 19, 2004·Toxicologic Pathology·Daniel MortonJeffrey R May
Mar 14, 2002·Toxicologic Pathology·Eugenia FloydRicardo Ochoa
Jul 20, 2000·Molecular Carcinogenesis·H OhgakiL A Donehower
Sep 19, 2019·Toxicologic Pathology·Cynthia L Willard-MackCharlotte M Keenan
Dec 24, 2005·Toxicological Sciences : an Official Journal of the Society of Toxicology·R E StollJ H Mennear

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.